MohamadAliCherryMD
Oncology • Morristown, NJAssociate Professor, Medicine, University of Oklahoma College of Medicine
Dr. Cherry is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
100 Madison Avenue
2nd Floor
Morristown, NJ 07960- Is this information wrong?
Summary
- Prior to joining Atlantic Health System Cancer Care, where he will add to the team’s ability to treat leukemia, lymphoma and myeloma, Dr. Cherry held appointments as associate professor of medicine (hematology/oncology), director of the hematology/oncology fellowship program, Mai Eager Anderson Endowed Chair in clinical trials and co-chair of the Academy of Teaching Scholars Faculty Development, Education and Mentoring Committee at the University of Oklahoma Health Sciences Center Stephenson Cancer Center. He also co-chaired the Leukemia Working Group at the Sarah Cannon Research Institute Blood Cancer Consortium. As principal investigator of multiple clinical trials, Dr. Cherry has performed groundbreaking research in the development of new therapeutics for relapsed and refractory blood cancers. He has also focused his research on studying epigenetics as biomarkers for response to chemotherapy in osteosarcoma. He has led Phase I, II and III clinical trials, funded by the National Cancer Institute and pharmaceutical companies.
Dr. Cherry has published a number of books and book chapters, and has served as lead author or co-author of more than 20 peer-reviewed papers published in leading scientific journals. He has lectured locally, nationally and internationally, and has presented or published his research at premier hematology/oncology meetings sponsored by ASH and the American Society of Clinical Oncology (ASCO), among others.
Dr. Cherry is the recipient of numerous awards for his research, clinical and educational pursuits, including ASH HONORS for Hematology Opportunities for the Next Generation of Research Scientists (as a mentor) and the Medal of Excellency from the Board of Specialization and Academic Orientation – Lebanese University, Beirut. In 2015, he was selected as Hematology Advocate by the ASH Advocacy Leadership Institute.
Education & Training
Oklahoma University Health Sciences CenterMS, Clinical and Translational Research, 2012 - 2015
University of Oklahoma Health Sciences CenterFellowship, Hematology and Medical Oncology, 2008 - 2011
Zucker School of Medicine at Hofstra/Northwell at Staten Island University HospitalResidency, Internal Medicine, 2003 - 2006
Lebanese University School of MedicineClass of 2001- Lebanese University-Faculty of SciencesNo Degree, Biologic Sciences, 1994 - 1995
Certifications & Licensure
NJ State Medical License 2017 - 2025
OK State Medical License 2006 - 2021- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Best Clinical Vignette Award Oklahoma ACP Chapter, 2016
- Selected as Hematology Advocate American Society of Hematology (ASH) Advocacy Leadership Institute, 2015
- Elected Honorable Member Academy of Teaching Scholars at the Oklahoma University Health Sciences Center, 2015
- Join now to see all
Clinical Trials
- Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia Start of enrollment: 2009 Jan 29
- Trial of Erlotinib in Patients With JAK-2 V617F Positive Polycythemia Vera Start of enrollment: 2009 Dec 01
- Ofatumumab and Bendamustine Hydrochloride With or Without Bortezomib in Treating Patients With Untreated Follicular Non-Hodgkin Lymphoma Start of enrollment: 2011 Apr 08
- Join now to see all
Publications & Presentations
PubMed
- 2 citationsGilteritinib in Combination With Induction and Consolidation Chemotherapy and as Maintenance Therapy: A Phase IB Study in Patients With Newly Diagnosed AML.Keith W Pratz, Mohamad Cherry, Jessica K Altman, Brenda W Cooper, Nikolai A Podoltsev, Jose Carlos Cruz, Tara L Lin, Gary J Schiller, Joseph G Jurcic, Adam Asch, Ruish...> ;Journal of Clinical Oncology. 2023 Sep 10
- 10 citationsHematopoietic Cell Transplant for Blastic Plasmacytoid Dendritic Cell Neoplasm.Mohamed A. Kharfan-Dabaja, Mohamad Cherry> ;Hematology/oncology Clinics of North America. 2020 Jun 1
- 1 citationsGranulocytic sarcoma and mediastinal germ cell tumor: A common cell of origin?Sarbajit Mukherjee, Sami Ibrahimi, Teresa Scordino, Mohamad Cherry> ;Hematology/oncology and Stem Cell Therapy. 2019 Dec 1
- Join now to see all
Journal Articles
- Secondary solid tumors and lymphoma in patients with essential thrombocythemia and polycythemia vera-single center experienceMasarova L, Cherry M, Newberry KJ Estrov Z, Cortes JE, Kantarjian HM, Verstovsek S, Leuk Lymphoma, 1/22/2015
- Prospective evaluation of protein C and factor VIII in prediction of cancer-associated thrombosisTafur AJ, Dale G, Cherry M, Wren JD, Mansfield AS, Comp P, Rathbun S, Stoner JA, Thromb Res, 1/1/2015
- Erlotinib is not effective in patients with JAK2V617F-positive polycythemia veraCherry M, Khawandanah M, Zhao ZJ, Srour S, Ozer H, Selby G, Ghabache B, Al-Kali A, Ann Hematol, 1/9/2014
- Join now to see all
Books/Book Chapters
Abstracts/Posters
- Using in-vitro and in-vivo studies to personalize therapy for AML.Suraj Pratap, Wanke Zhao, Richard A. Allen, Mohamad Cherry, Joe Z. Zhao, American Society of Pediatric Hematology & Oncology (ASPHO) Annual Meeting, 1/1/2017
- Extra-nodal marginal zone lymphoma (malt lymphoma) in the central Nervous system presenting as a meningioma.Adanma Ayanambakkam, MD, Alekhya Mitta, MBBS Khalid Bilal, MD & Mohamed Cherry, MD, Oklahoma ACP Chapter Meeting, 1/1/2016
- Further Evidence to Not Delay Transplant for Continued ARA-C Consolidation in Patients with Intermediate or High Risk AML.James K. Feisal, Nicholas B. Pleat, Michael Machiorlatti, Summer Frank, Sara Vesley, Sarah Schmidt, George Selby, Carrie Yuen, Jennifer L Holter-Chakrabarty, Mohamad C..., Blood, 1/4/2015
- Join now to see all
Lectures
- Descriptive Study of Genome-Wide DNA Methylation Patterns in Osteosarcoma Tissues and Their Potential Role as Predictive Biomarkers for Chemotherapy Response.Oklahoma City - 1/1/2015
- "Acute Leukemia"University of Oklahoma Health Sciences Center - 1/1/2015
- "Leukemia & Lymphoma"University of Oklahoma Health Sciences Center, 2013, 2015 - 1/1/2015
- Join now to see all
Press Mentions
Atlantic Health Presents 7 Studies at Prestigious ASCO MeetingJune 9th, 2021- 7 Studies at American Society of Clinical Oncology (ASCO) Annual Meeting Presented by Atlantic Health System Cancer Care Physician ResearchersJune 7th, 2021
- Dr. Mohamad Cherry of Atlantic Health System Presents Studies at Top International Blood Cancer MeetingFebruary 17th, 2021
- Join now to see all
Professional Memberships
- Member
Other Languages
- Arabic, French
Hospital Affiliations
Morristown Medical CenterMorristown, New Jersey
External Links
- SCC Profilehttp://stephensoncancercenter.org/PhysicianFinder/PhysicianDetails/TabId/7310/ArtMID/18739/ArticleID/220/Mohamad-Cherry-MD.aspx
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
